Russell Investments Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.5M | Sell |
156,383
-9,955
| -6% | -$286K | 0.01% | 1279 |
|
|
2025
Q1 | $5.58M | Buy |
166,338
+132,138
| +386% | +$4.43M | 0.01% | 1103 |
|
|
2024
Q4 | $1.75M | Sell |
34,200
-43,501
| -56% | -$2.22M | ﹤0.01% | 1740 |
|
|
2024
Q3 | $3.97M | Sell |
77,701
-24,693
| -24% | -$1.26M | 0.01% | 1313 |
|
|
2024
Q2 | $4.59M | Buy |
102,394
+51,060
| +99% | +$2.29M | 0.01% | 1192 |
|
|
2024
Q1 | $2.4M | Buy |
51,334
+51,320
| +366,571% | +$2.4M | ﹤0.01% | 1552 |
|
|
2023
Q4 | $498 | Hold |
14
| – | – | ﹤0.01% | 3127 |
|
|
2023
Q3 | $416 | Buy |
+14
| New | +$416 | ﹤0.01% | 3424 |
|
|
2022
Q1 | – | Sell |
-843
| Closed | -$23K | – | 2782 |
|
|
2021
Q4 | $23K | Sell |
843
-82,261
| -99% | -$2.24M | ﹤0.01% | 2945 |
|
|
2021
Q3 | $1.75M | Buy |
+83,104
| New | +$1.75M | ﹤0.01% | 1910 |
|
|
2021
Q2 | – | Sell |
-14,001
| Closed | -$213K | – | 3221 |
|
|
2021
Q1 | $213K | Buy |
14,001
+4,019
| +40% | +$61.1K | ﹤0.01% | 2805 |
|
|
2020
Q4 | $140K | Buy |
9,982
+8,782
| +732% | +$123K | ﹤0.01% | 2825 |
|
|
2020
Q3 | $18K | Sell |
1,200
-4,400
| -79% | -$66K | ﹤0.01% | 3140 |
|
|
2020
Q2 | $98K | Buy |
+5,600
| New | +$98K | ﹤0.01% | 2886 |
|